Concepedia

Author

Yingxia Ning

First Affiliated Hospital of Guangzhou Medical University

Also Known As

YING-XIA NING, YINGXIA NING, Ying-Xia Ning, Yingxia Ning

28

Publications

620

Citations

14

H-Index

24

Concepts

All Affiliations

First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou Medical UniversityHunan Normal UniversityFirst Affiliated Hospital of Jinan UniversityTCM-Intigrated Cancer Center of Southern Medical University
YN

About

Yingxia Ning is an author at First Affiliated Hospital of Guangzhou Medical University specializing in medicine, tumor biology, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

161

2

Health Sciences

3

3

150

3

Cell Biology

3

3

150

4

Emergency Medicine

1

1

11

5

Immunology

1

1

78

Yingxia Ning

×

14

Publications

534

Citations

13

H-Index

YearCitations

Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression

Yuao Deng, Fang Zhao, Hui Liu,

Journal of Ovarian Research

2017

82

Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling

Yingxia Ning, Yinghong Cui, Xiang Li,

Biomedicine & Pharmacotherapy

2018

78

miR-6089/MYH9/β-catenin/c-Jun negative feedback loop inhibits ovarian cancer carcinogenesis and progression

Longyang Liu, Yingxia Ning, Juanjuan Yi,

Biomedicine & Pharmacotherapy

2020

63

RETRACTED ARTICLE: Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8/STAT3 axis

Yingxia Ning, Weifeng Feng, Xiaocheng Cao,

Journal of Experimental & Clinical Cancer Research

2019

56

FOXO3a-mediated suppression of the self-renewal capacity of sphere-forming cells derived from the ovarian cancer SKOV3 cell line by 7-difluoromethoxyl-5,4′-di-n-octyl genistein

Yingxia Ning, Chaoyuan Luo, Kaiqun Ren,

Molecular Medicine Reports

2014

39

Inactivation of AKT, ERK and NF-κB by genistein derivative, 7-difluoromethoxyl-5,4′-di-n-octylygenistein, reduces ovarian carcinoma oncogenicity

Yingxia Ning, Meng Xu, Xiaocheng Cao,

Oncology Reports

2017

34

7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian cancer stem cell characteristics through the downregulation of FOXM1

Yingxia Ning, Qingxiu Li, Kaiqun Ren,

Oncology Letters

2014

33

Drug repositioning of disulfiram induces endometrioid epithelial ovarian cancer cell death via the both apoptosis and cuproptosis pathways

Y Gan, Ting Liu, Weifeng Feng,

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics

2023

29

High Expression of MYL9 Indicates Poor Clinical Prognosis of Epithelial Ovarian Cancer

Yuao Deng, Longyang Liu, Weifeng Feng,

Recent Patents on Anti-Cancer Drug Discovery

2021

28

Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc

Yingxia Ning, Xin Luo, Meng Xu,

Oncotarget

2017

25

Page 1